Director Fred E. Cohen filed a Form 4 with the SEC on November 4, 2026, disclosing a disposition of 25,000 shares of CareDx, Inc. common stock on November 3, 2026, via a gift transaction.

Key Highlights

  • Reporting person: Fred E. Cohen, identified in the filing as a Director of CareDx, Inc. (NASDAQ:CDNA).
  • Transaction type: Code "G" transaction, indicating a gift, with 25,000 shares disposed of (D) at a price of $0.
  • Transaction date: November 3, 2026.
  • Remaining holdings: Cohen directly beneficially owned 140,060 shares of common stock following the reported transaction.
  • Filing type: Direct ownership; filed by one reporting person, signed by Jeffrey Adam Novack as Attorney-in-Fact.

Fred E. Cohen's November 2026 Gift Disposition at CareDx

According to the filing, Fred E. Cohen, a Director of CareDx, Inc., reported a single transaction in Table I covering non-derivative securities. On November 3, 2026, Cohen disposed of 25,000 shares of CareDx common stock under transaction code "G," which the form uses to designate a gift. The price recorded for the transaction was $0, consistent with the gift designation.

Following the disposition, the filing reports that Cohen directly beneficially owned 140,060 shares of CareDx common stock. No derivative securities transactions were reported in Table II of the filing. The form was signed on November 3, 2026, by Jeffrey Adam Novack as Attorney-in-Fact for the reporting person, and was filed with the SEC on November 4, 2026.

The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox on the form was not checked. No amendment date was listed, indicating this is an original filing rather than a revision to a previously submitted Form 4.

What Was Disclosed

The filing disclosed a gift disposition of 25,000 CareDx common shares by Director Fred E. Cohen on November 3, 2026, at $0, leaving Cohen with direct beneficial ownership of 140,060 shares following the transaction.